SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending due to a significant stock drop following mixed results from a Phase 3 trial for their skin disease drug, sonelokimab. The community is actively discussing whether the sell-off is an overreaction, with some citing the company's strong cash position and potential for a buyout, while others focus on the trial's shortcomings and competitive landscape. Traders are weighing potential bounce opportunities against the risk of further decline in this volatile biotech stock.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

CCL is trending as investors react to positive earnings, a raised FY25 outlook, and updates on fleet and destinations. While some community members anticipate further gains as the cruise industry recovers, others are wary of a post-earnings pullback. Bullish sentiment cites strong bookings and increased guidance, while bears point to potential accounting fraud and an antiquated business model.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending amid ongoing discussions around potential cannabis rescheduling, spurred by commentary regarding Trump's views on medical cannabis. The community is actively debating the likelihood and timing of federal action, with some expressing optimism about potential catalysts. Bullish sentiment focuses on the potential impact of rescheduling on cannabis companies and the broader sector.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid speculation that the company may enter a bidding war for Warner Bros. Discovery, potentially intensifying competition in the streaming space. Community members are actively discussing potential price targets, the impact of upcoming events like the Canelo vs. Crawford fight, and overall market sentiment. Some traders believe the stock is oversold and poised for a rebound, while others express concerns about valuation and near-term margin pressures.

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Dogwood Therapeutics Inc.

Dogwood Therapeutics is trending due to a recent licensing agreement for a cancer-related pain treatment, sparking community excitement.  Traders are highlighting its low float and potential for a significant upward move, drawing comparisons to other stocks with similar setups. Optimism surrounds upcoming catalysts and the possibility of a substantial price increase.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending after multiple analysts raised their price targets, citing the upcoming launch of its non-gaming self-serve tool and potential growth in ad revenue. The community is debating whether the stock is in bubble territory, while some traders are attempting to time pullbacks and short the stock, others suggest the stock may be influenced by news regarding TikTok. Bullish sentiment remains strong overall, as the stock approaches new all-time highs, with some anticipating further price target increases.

WiMi Hologram Cloud, Inc. engages in the provision of holographic services and products. It offers comprehensive solutions including AR automotive HUD software, 3D holographic pulse LiDAR, head-mounted light field equipment, holographic semiconductors, cloud software, and car navigation systems. Its services and holographic AR technologies include holographic AR automotive application, 3D holographic pulse LiDAR technology, holographic vision semiconductor technology, holographic software development, holographic AR advertising technology, holographic AR entertainment technology, holographic ARSDK payment, interactive holographic communication and other holographic AR technologies. The firm operates through the following segments: AR Advertising Services, AR Entertainment, and Semiconductor Business. The AR Advertising Services segment enables the integration of real or animated 3D objects into video footage, creating seamless and interactive visual experiences. The AR Entertainment segment focuses on payment middleware software, game distribution platforms, and holographic MR software. The Semiconductor Business segment provides central processing algorithm services, computer chip products, and comprehensive solutions integrating software and hardware for enterprise customers. The company was founded by Jie Zhao in May 2015 and is headquartered in Chaoyang, China.

Wimi Hologram Cloud Inc - Ordinary Shares - Class B

Wimi Hologram Cloud Inc - ADR

WIMI is trending as investors discuss the company's recent net income growth and significant cash reserves, leading to debates about its valuation. Community members are weighing the potential for a squeeze against concerns about the company's business practices and past performance, particularly in relation to other related stocks. The conversation includes the company's involvement in AI, quantum computing, and holographic technology.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending as cannabis stocks surge following reports that Trump is considering reclassifying marijuana, sparking excitement about potential rescheduling. The community is actively discussing the possibility of a short squeeze and the impact on Canadian LPs, while emphasizing ACB's strong position in the medical cannabis sector and its undervaluation. Traders are closely watching for further news and a breakout, anticipating significant gains in the near future.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

GTBIF is trending as cannabis stocks react to potential rescheduling catalysts, with community members expressing confidence due to insider buying and anticipating further upward movement. The discussion also includes differing viewpoints on the likelihood and potential impact of federal cannabis reform, with some highlighting the company's strong financial position. Investors are closely watching for news that could impact the sector, while others remain skeptical of any near-term changes.

Electronic Arts, Inc. engages in the development, marketing, publication, and distribution of games, content, and services for game consoles, PCs, mobile phones, and tablets. The company develops and publishes games and services across various genres, such as sports, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Anthem, Need for Speed, and Plants v. Zombies brands, and license games, including FIFA, Madden NFL, and Star Wars brands. The firm also provides advertising services and licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution channels, as well as through retail channels, such as mass-market retailers, electronics specialty stores, and game software specialty stores. The company was founded by William M. Hawkins III and William Gordon in 1982 and is headquartered in Redwood City, CA.

Electronic Arts, Inc.

Electronic Arts is trending amid speculation of a potential buyout, with community members debating the merits of buying shares at a premium. A possible take-private deal involving firms like Silver Lake and Saudi Arabia's PIF has sparked discussions about the future of EA and its game development. Some traders are also noting technical indicators and director buys that could lead to a breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dogwood Therapeutics, Inc. (DWTX) shares surged 50% in the pre-market session on Monday after the company announced that it has secured a license to develop Serpin Pharma’s intravenous formulation of SP16 to manage cancer-related pain (CRP).The royalty-free, global license will enable the company to develop SP16 for a broad range of chemotherapy-induced neuropathy symptoms as well.In return, Sepin Pharma and its designated affiliates will get 7.31% of the company’s common stock, on a fully diluted basis. This includes 382,034 shares of DWTX common stock and 179.1878 shares of a new series of non-voting convertible preferred stock, it said.Get updates to this developing story <a href="https://stocktwits.com/news-articles/markets/equity/dogwood-therapeutics-stock-soars-pre-market-on-securing-license-for-cancer-related-pain-management-drug/chDubC3R3J2">directly on Stocktwits.</a>

Rising stock market chart on a trading board background.

Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug 

In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis.

Equity

In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis.


Frame 485.png

Get the daily email that keeps you tuned in and makes markets fun again.

Frame 484.png

The most relevant Indian markets intel delivered to you everyday.

cryptotwits - 800x800.png

Get the daily crypto email you’ll actually love to read. It's value-packed, data-driven, and seasoned with wit.

Frame 479.png

The best trade ideas and analysis from the Stocktwits community. Delivered daily by 8 pm ET.

Frame 486.png

For serious investors with a serious sense of humor.

Frame 487.png

High Relative Strength, Low Social Following

Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug

Latest News